NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,132 | +241.0% | 70 | +775.0% | 0.00% | – |
| Q2 2023 | $332 | -87.5% | 8 | -81.8% | 0.00% | -100.0% |
| Q1 2023 | $2,647 | -21.5% | 44 | -4.3% | 0.00% | 0.0% |
| Q4 2022 | $3,374 | +12.5% | 46 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | 0.0% | 46 | -8.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | 0.0% | 50 | +31.6% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | +50.0% | 38 | +15.2% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 33 | +266.7% | 0.00% | – |
| Q3 2021 | $1,000 | -90.0% | 9 | -79.1% | 0.00% | -100.0% |
| Q2 2021 | $10,000 | +400.0% | 43 | +437.5% | 0.00% | +200.0% |
| Q1 2021 | $2,000 | 0.0% | 8 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | – | 8 | +100.0% | 0.00% | – |
| Q3 2020 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |